ECM remodeling by tumor-associated fibroblasts (CAFs), which secrete resistance-promoting cytokines like TGF-β and VEGF, further modifies the tumor microenvironment (Liao et al., 2019; Guo and Xu, 2024). This evidence concerns the gene TGFB1 and neoplasm.